Vanda Pharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- Vanda Pharmaceuticals's estimated annual revenue is currently $300M per year.
- Vanda Pharmaceuticals's estimated revenue per employee is $1,056,338
- Vanda Pharmaceuticals's total funding is $72.5M.
Employee Data
- Vanda Pharmaceuticals has 284 Employees.
- Vanda Pharmaceuticals grew their employee count by -15% last year.
Vanda Pharmaceuticals's People
| Name | Title | Email/Phone |
|---|---|---|
1 | VP, Manufacturing | Reveal Email/Phone |
2 | SVP, Business Development | Reveal Email/Phone |
3 | V.P. Business Development | Reveal Email/Phone |
4 | VP, Head Compliance | Reveal Email/Phone |
5 | VP Sales, Commercial | Reveal Email/Phone |
6 | Controller | Reveal Email/Phone |
7 | SVP General Counsel & Secretary | Reveal Email/Phone |
8 | Director IT | Reveal Email/Phone |
9 | Data Scientist | Reveal Email/Phone |
10 | VP, Medical Director | Reveal Email/Phone |
Vanda Pharmaceuticals Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $13.7M | 31 | -14% | N/A | N/A |
#2 | $7.2M | 36 | 6% | N/A | N/A |
#3 | $17.7M | 88 | 40% | N/A | N/A |
#4 | $28.7M | 143 | 5% | N/A | N/A |
#5 | $1.4M | 7 | N/A | N/A | N/A |
#6 | $15.3M | 76 | 1% | N/A | N/A |
#7 | $596.4M | 2967 | 9% | N/A | N/A |
#8 | $5.4M | 27 | -10% | N/A | N/A |
#9 | $86.8M | 432 | 7% | N/A | N/A |
#10 | $5M | 25 | 4% | N/A | N/A |
What Is Vanda Pharmaceuticals?
Vanda Pharmaceuticals was founded in 2003 via a venture partnership between Care Capital and the Bio*One Capital of the Singapore Economic Development Board. The inspiration for the company evolved out of the pharmaceutical industry experience of Dr. Jerry Karabelas of Care Capital, former CEO of Worldwide Pharmaceuticals for Novartis AG and Executive Vice President at SmithKline Beecham, and Dr. Mihael Polymeropoulos, CEO of Vanda Pharmaceuticals, who founded and headed the Pharmacogenetics Department at Novartis AG.
keywords:N/A
$72.5M
Total Funding
284
Number of Employees
$300M
Revenue (est)
-15%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Vanda Pharmaceuticals News
Despite its losses, the stock outperformed some of its competitors Thursday, as Fate Therapeutics Inc. FATE, -5.68% fell 5.68% to $34.52, Vanda...
Law360 (April 7, 2022, 3:25 PM EDT) -- Vanda Pharmaceuticals Inc. has hit the U.S. Food and Drug Administration with a lawsuit asking a Washington, D.C.,...
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Holdings Trimmed by Dupont Capital Management Corp. Posted by admin on Apr 11th, 2022.
WASHINGTON, Nov. 10, 2021 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that Vanda management will participate at the following upcoming investor conferences in November 2021: The Stifel 2021 Virtual Healthcare Conference on Monday, November 15, 2021. A corpo ...
WASHINGTON, Oct. 27, 2021 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced it will release results for the third quarter 2021 on Wednesday, November 3, 2021, after the market closes. Vanda will host a conference call at 4:30 PM ET on Wednesday, November 3, 2021, ...
Other Companies in Washington
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $45.8M | 287 | 4% | N/A |
#2 | $56.8M | 287 | N/A | N/A |
#3 | $35M | 287 | -2% | N/A |
#4 | $55.4M | 288 | 49% | N/A |
#5 | $15M | 288 | 5% | N/A |